These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
534 related items for PubMed ID: 19301004
1. Antimony-trioxide- and arsenic-trioxide-induced apoptosis in myelogenic and lymphatic cell lines, recruitment of caspases, and loss of mitochondrial membrane potential are enhanced by modulators of the cellular glutathione redox system. Lösler S, Schlief S, Kneifel C, Thiel E, Schrezenmeier H, Rojewski MT. Ann Hematol; 2009 Nov; 88(11):1047-58. PubMed ID: 19301004 [Abstract] [Full Text] [Related]
2. Depolarization of mitochondria and activation of caspases are common features of arsenic(III)-induced apoptosis in myelogenic and lymphatic cell lines. Rojewski MT, Körper S, Thiel E, Schrezenmeier H. Chem Res Toxicol; 2004 Jan; 17(1):119-28. PubMed ID: 14727926 [Abstract] [Full Text] [Related]
3. Arsenic trioxide induces apoptosis in cells of MOLT-4 and its daunorubicin-resistant cell line via depletion of intracellular glutathione, disruption of mitochondrial membrane potential and activation of caspase-3. Hu XM, Hirano T, Oka K. Cancer Chemother Pharmacol; 2003 Jul; 52(1):47-58. PubMed ID: 12750841 [Abstract] [Full Text] [Related]
4. Elimination of the differential chemoresistance between the murine B-cell lymphoma LY-ar and LY-as cell lines after arsenic (As2O3) exposure via the overexpression of gsto1 (p28). Giri U, Terry NH, Kala SV, Lieberman MW, Story MD. Cancer Chemother Pharmacol; 2005 Jun; 55(6):511-21. PubMed ID: 15761769 [Abstract] [Full Text] [Related]
5. Quercetin decreases intracellular GSH content and potentiates the apoptotic action of the antileukemic drug arsenic trioxide in human leukemia cell lines. Ramos AM, Aller P. Biochem Pharmacol; 2008 May 15; 75(10):1912-23. PubMed ID: 18359480 [Abstract] [Full Text] [Related]
6. Arsenic trioxide-induced apoptosis and its enhancement by buthionine sulfoximine in hepatocellular carcinoma cell lines. Kito M, Akao Y, Ohishi N, Yagi K, Nozawa Y. Biochem Biophys Res Commun; 2002 Mar 08; 291(4):861-7. PubMed ID: 11866444 [Abstract] [Full Text] [Related]
7. Sodium selenite induces apoptosis in acute promyelocytic leukemia-derived NB4 cells by a caspase-3-dependent mechanism and a redox pathway different from that of arsenic trioxide. Zuo L, Li J, Yang Y, Wang X, Shen T, Xu CM, Zhang ZN. Ann Hematol; 2004 Dec 08; 83(12):751-8. PubMed ID: 15480664 [Abstract] [Full Text] [Related]
8. Methylated metabolites of arsenic trioxide are more potent than arsenic trioxide as apoptotic but not differentiation inducers in leukemia and lymphoma cells. Chen GQ, Zhou L, Styblo M, Walton F, Jing Y, Weinberg R, Chen Z, Waxman S. Cancer Res; 2003 Apr 15; 63(8):1853-9. PubMed ID: 12702573 [Abstract] [Full Text] [Related]
9. Enhancement of arsenic trioxide-induced apoptosis in renal cell carcinoma cells by L-buthionine sulfoximine. Wu XX, Ogawa O, Kakehi Y. Int J Oncol; 2004 Jun 15; 24(6):1489-97. PubMed ID: 15138592 [Abstract] [Full Text] [Related]
10. Pharmacologic inhibitors of extracellular signal-regulated kinase (ERKs) and c-Jun NH(2)-terminal kinase (JNK) decrease glutathione content and sensitize human promonocytic leukemia cells to arsenic trioxide-induced apoptosis. Ramos AM, Fernandez C, Amrán D, Esteban D, de Blas E, Palacios MA, Aller P. J Cell Physiol; 2006 Dec 15; 209(3):1006-15. PubMed ID: 16972261 [Abstract] [Full Text] [Related]
11. Arsenic trioxide-induced apoptosis of Hep-2 cell line through modulating intracellular glutathione (GSH) level. Cheng B, Yang X, An L, Gao B, Liu X. Auris Nasus Larynx; 2010 Feb 15; 37(1):89-94. PubMed ID: 19574005 [Abstract] [Full Text] [Related]
12. Arsenic induces apoptosis of multidrug-resistant human myeloid leukemia cells that express Bcr-Abl or overexpress MDR, MRP, Bcl-2, or Bcl-x(L). Perkins C, Kim CN, Fang G, Bhalla KN. Blood; 2000 Feb 01; 95(3):1014-22. PubMed ID: 10648417 [Abstract] [Full Text] [Related]
13. Combination treatment with arsenic trioxide and irradiation enhances apoptotic effects in U937 cells through increased mitotic arrest and ROS generation. Ho SY, Chen WC, Chiu HW, Lai CS, Guo HR, Wang YJ. Chem Biol Interact; 2009 May 15; 179(2-3):304-13. PubMed ID: 19159621 [Abstract] [Full Text] [Related]
14. Enhancement of arsenic trioxide-induced apoptosis in HeLa cells by diethyldithiocarbamate or buthionine sulfoximine. Han YH, Kim SZ, Kim SH, Park WH. Int J Oncol; 2008 Jul 15; 33(1):205-13. PubMed ID: 18575767 [Abstract] [Full Text] [Related]
15. Involvement of a Rho-ROCK-JNK pathway in arsenic trioxide-induced apoptosis in chronic myelogenous leukemia cells. Potin S, Bertoglio J, Bréard J. FEBS Lett; 2007 Jan 09; 581(1):118-24. PubMed ID: 17182041 [Abstract] [Full Text] [Related]
16. Arsenic trioxide induces multiple myeloma cell apoptosis via disruption of mitochondrial transmembrane potentials and activation of caspase-3. Jia P, Chen G, Huang X, Cai X, Yang J, Wang L, Zhou Y, Shen Y, Zhou L, Yu Y, Chen S, Zhang X, Wang Z. Chin Med J (Engl); 2001 Jan 09; 114(1):19-24. PubMed ID: 11779429 [Abstract] [Full Text] [Related]
17. Enhancement of esculetin on arsenic trioxide-provoked apoptosis in human leukemia U937 cells. Lin TH, Lu FJ, Yin YF, Tseng TH. Chem Biol Interact; 2009 Jun 15; 180(1):61-8. PubMed ID: 19428345 [Abstract] [Full Text] [Related]
18. Arsenic trioxide inhibits cell growth in SH-SY5Y and SK-N-AS neuroblastoma cell lines by a different mechanism. Woo SY, Lee MY, Jung YJ, Yoo ES, Seoh JY, Shin HY, Ahn HS, Ryu KH. Pediatr Hematol Oncol; 2006 Jun 15; 23(3):231-43. PubMed ID: 16517539 [Abstract] [Full Text] [Related]
19. Induction of autophagic cell death in malignant glioma cells by arsenic trioxide. Kanzawa T, Kondo Y, Ito H, Kondo S, Germano I. Cancer Res; 2003 May 01; 63(9):2103-8. PubMed ID: 12727826 [Abstract] [Full Text] [Related]
20. JWA is required for arsenic trioxide induced apoptosis in HeLa and MCF-7 cells via reactive oxygen species and mitochondria linked signal pathway. Zhou J, Ye J, Zhao X, Li A, Zhou J. Toxicol Appl Pharmacol; 2008 Jul 01; 230(1):33-40. PubMed ID: 18387645 [Abstract] [Full Text] [Related] Page: [Next] [New Search]